#CNBC FDA fast-tracks psychedelic drug research following Trump executive order

FDA fast-tracks psychedelic drug research following Trump executive order
The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness.

CNBC’s Brandon Gomez has the details.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”